| $385M | ||
| $337M | ||
| $100M | ||
| $87M | ||
| $82M | ||
| $62M |
Buys | $35,183,395 | 6 | 100 |
Sells | $0 | 0 | 0 |
| CHILDS JOHN W | director | 3 | $27.04M | 0 | $0 | $27.04M |
| Coric Vlad | Chief Executive Officer | 1 | $5M | 0 | $0 | $5M |
| Bailey Gregory | director | 1 | $3M | 0 | $0 | $3M |
| Clark George C. | VP, Chief Accounting Officer | 1 | $144,770 | 0 | $0 | $144,770 |
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Over the last 12 months, insiders at Biohaven Ltd. have bought $35.18M and sold $0 worth of Biohaven Ltd. stock.
On average, over the past 5 years, insiders at Biohaven Ltd. have bought $29.29M and sold $5.9M worth of stock each year.
Highest buying activity among insiders over the last 12 months: CHILDS JOHN W (director) — $27.04M. Coric Vlad (Chief Executive Officer) — $5M. Bailey Gregory (director) — $3M.
The last purchase of 17,000 shares for transaction amount of $144,770 was made by Clark George C. (VP, Chief Accounting Officer) on 2025‑11‑17.
| 2025-11-17 | Clark George C. | VP, Chief Accounting Officer | 17,000 0.0165% | $8.52 | $144,770 | +9.41% | ||
| 2025-11-13 | CHILDS JOHN W | director | 3.33M 2.9193% | $7.50 | $25M | +13.01% | ||
| 2025-11-13 | Bailey Gregory | director | 400,000 0.3503% | $7.50 | $3M | +13.01% | ||
| 2025-11-13 | Coric Vlad | Chief Executive Officer | 666,666 0.5839% | $7.50 | $5M | +13.01% | ||
| 2025-03-04 | CHILDS JOHN W | director | 32,700 0.0315% | $30.47 | $996,238 | -50.64% | ||
| 2024-12-30 | CHILDS JOHN W | director | 29,000 0.0281% | $35.94 | $1.04M | -55.51% | ||
| 2024-10-02 | Coric Vlad | Chief Executive Officer | 21,052 0.0215% | $47.50 | $999,970 | -52.63% | ||
| 2024-10-02 | CHILDS JOHN W | director | 21,052 0.0215% | $47.50 | $999,970 | -52.63% | ||
| 2024-09-24 | Bailey Gregory | director | 5,000 0.0047% | $44.19 | $220,966 | -38.02% | ||
| 2024-07-18 | CHILDS JOHN W | director | 28,400 0.0218% | $35.67 | $1.01M | +6.44% | ||
| 2024-06-17 | Car Bruce | Chief Scientific Officer | 30,000 0.0217% | $33.58 | $1.01M | +13.11% | ||
| 2024-05-30 | CHILDS JOHN W | director | 28,000 0.0214% | $35.58 | $996,240 | +5.92% | ||
| 2024-05-13 | CHILDS JOHN W | director | 28,500 0.0215% | $35.17 | $1M | +11.81% | ||
| 2024-05-13 | Bailey Gregory | director | 15,000 0.011% | $34.19 | $512,877 | +11.81% | ||
| 2024-04-24 | Bailey Gregory | director | 25,503 0.0215% | $39.18 | $999,169 | -1.32% | ||
| 2024-04-22 | Coric Vlad | Chief Executive Officer | 121,951 0.1075% | $41.00 | $5M | -0.05% | ||
| 2024-04-22 | Bailey Gregory | director | 48,780 0.043% | $41.00 | $2M | -0.05% | ||
| 2024-04-22 | CHILDS JOHN W | director | 73,170 0.0645% | $41.00 | $3M | -0.05% | ||
| 2023-12-29 | Sale | Antonijevic Irina | director | 11,000 0.0099% | $41.79 | $459,663 | -0.12% | |
| 2023-10-05 | CHILDS JOHN W | director | 454,545 0.2149% | $22.00 | $10M | +61.12% |
| CHILDS JOHN W | director | 5653904 5.3407% | $53.99M | 22 | 2 | +27.3% |
| Bailey Gregory | director | 2020071 1.9082% | $19.29M | 10 | 22 | +9.89% |
| Coric Vlad | Chief Executive Officer | 1195275 1.1291% | $11.41M | 9 | 8 | +10.59% |
| Clark George C. | VP, Chief Accounting Officer | 20000 0.0189% | $191,000.00 | 1 | 3 | |
| Cha Albert | director | 1976818 1.8673% | $18.88M | 1 | 0 | |
| Doogan Declan | director | 870648 0.8224% | $8.31M | 0 | 31 | |
| Buten Matthew | Chief Financial Officer | 189380 0.1789% | $1.81M | 2 | 0 | +39.3% |
| PORTAGE BIOTECH INC. | 54494 0.0515% | $520,417.70 | 0 | 7 | ||
| Car Bruce | Chief Scientific Officer | 30000 0.0283% | $286,500.00 | 1 | 0 | +13.11% |
| GREGORY JULIA P | director | 25665 0.0242% | $245,100.75 | 1 | 3 | +17.49% |
| Engelhart James | Chief Financial Officer | 11196 0.0106% | $106,921.80 | 2 | 9 | |
| Stock Elyse | Chief Medical Officer | 7467 0.0071% | $71,309.85 | 0 | 5 | |
| Conway Charles | Chief Scientific Officer | 4000 0.0038% | $38,200.00 | 1 | 0 | |
| Gentile Kimberly | SVP, Clinical Operations | 3639 0.0034% | $34,752.45 | 0 | 11 | |
| Antonijevic Irina | director | 2535 0.0024% | $24,209.25 | 0 | 1 | |
| JONES WILLIAM A JR | CCO-Migraine & Common Disease | 1755 0.0017% | $16,760.25 | 0 | 1 | |
| AGUIAR ERIC | director | 1250 0.0012% | $11,937.50 | 0 | 7 | |
| Tilton John | Chief Commercial Officer | 770 0.0007% | $7,353.50 | 0 | 4 | |
| Berman Robert | Special Projects & Med Ovrsght | 341 0.0003% | $3,256.55 | 2 | 22 |
$26,838,605 | 98 | 5.37% | $966.22M | |
$61,783,526 | 37 | 18.57% | $1.08B | |
$150,196,329 | 28 | -8.09% | $1.07B | |
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) | $103,156,698 | 27 | 19.10% | $1.01B |
$7,598,498 | 27 | 34.68% | $1.03B | |
$49,750,490 | 17 | 37.19% | $1.04B | |
$26,254,270 | 14 | 24.18% | $939.99M | |
$133,809,976 | 13 | 31.29% | $929.13M | |
$18,336,420 | 12 | 24.03% | $1.06B | |
$11,541,901 | 10 | 8.07% | $1.04B | |
$5,794,001 | 10 | 23.26% | $1.02B | |
$117,959,652 | 9 | -12.47% | $949.13M | |
$1,580,951 | 9 | -14.18% | $1.08B | |
$160,798,946 | 8 | -3.92% | $993.02M | |
$46,235,722 | 6 | -31.77% | $1.01B | |
$21,792,890 | 6 | 75.72% | $975.05M | |
$19,420,853 | 5 | 4.35% | $1.07B | |
$45,070 | 4 | 10.31% | $933.08M | |
$33,624,000 | 2 | -50.37% | $996.99M |
| Increased Positions | 142 | +52.99% | 18M | +19.92% |
| Decreased Positions | 109 | -40.67% | 20M | -22.48% |
| New Positions | 51 | New | 2M | New |
| Sold Out Positions | 33 | Sold Out | 5M | Sold Out |
| Total Postitions | 301 | +12.31% | 86M | -2.57% |
| Blackrock, Inc. | $78,985.00 | 7.43% | 7.87M | +339,618 | +4.51% | 2025-09-30 |
| Janus Henderson Group Plc | $67,924.00 | 6.39% | 6.77M | +2M | +34.01% | 2025-09-30 |
| Stifel Financial Corp | $66,312.00 | 6.24% | 6.61M | +3,839 | +0.06% | 2025-09-30 |
| Suvretta Capital Management, Llc | $56,371.00 | 5.3% | 5.62M | 0 | 0% | 2025-09-30 |
| State Street Corp | $42,711.00 | 4.02% | 4.26M | +720,120 | +20.35% | 2025-09-30 |
| Vanguard Group Inc | $28,838.00 | 2.71% | 2.88M | -6M | -68.92% | 2025-09-30 |
| Bellevue Group Ag | $28,113.00 | 2.64% | 2.8M | 0 | 0% | 2025-09-30 |
| Fmr Llc | $24,342.00 | 2.29% | 2.43M | +761,991 | +45.77% | 2025-09-30 |
| Geode Capital Management, Llc | $20,664.00 | 1.94% | 2.06M | +29,289 | +1.44% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $20,156.00 | 1.9% | 2.01M | -1M | -36.63% | 2025-09-30 |